Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II …
Biotechnology
US, Lexington [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Cyteir Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Cyteir Therapeutics, Inc. has no acquisition track records yet.